Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 14, 2025 • 12:00 AM ET

Date/Time Source News Release
08/08/2023 06:50 AM EDT GlobeNewswire Bright Minds Biosciences Announces Positive qEEG (Quantitative Electroencephalogram) Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101
07/20/2023 06:50 AM EDT GlobeNewswire Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101
07/11/2023 06:50 AM EDT GlobeNewswire Bright Minds Announces Effective Date of Share Consolidation
06/22/2023 06:50 AM EDT GlobeNewswire Bright Minds Announces Proposed Share Consolidation
04/19/2023 06:50 AM EDT GlobeNewswire Bright Minds Biosciences Receives a Favorable Written Opinion from the International Searching Authority for BMB-202
04/10/2023 06:50 AM EDT GlobeNewswire Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research
02/27/2023 06:50 AM EST GlobeNewswire Bright Minds Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023
02/17/2023 06:50 AM EST GlobeNewswire Bright Minds Biosciences Announces Non-Executive Director Appointment
02/08/2023 04:05 PM EST GlobeNewswire Bright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent Director and Audit Committee Requirements
01/27/2023 04:05 PM EST GlobeNewswire Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
Page

Additional News

As of June 14, 2025 • 12:00 AM ET

Date/Time Source News Release
08/18/2022 04:14 PM EDT SeekingAlpha Bright Minds says no material events fueled rally
07/02/2021 12:05 PM EDT SeekingAlpha Bright Minds Biosciences: A Search For The GW Pharmaceuticals Of The Psilocybin Space
Page
  • 1